论文部分内容阅读
前列腺素E1(ProstaglandnE1，PGE1）是由环氧化酶作用形成的花生四烯酸（ArachidonicAcid，AA）代谢产物。自19657年被分离和以来，作为一种血管扩张药，经长期的动物实验和临床应用已证明，PGEI具有广泛的药理作用。近年来，有大量文献报道PGE；对治疗多种临床疾病疗效显著。
Prostaglandin E1 (PGE1) is an arachidonic acid (AA) metabolite formed by the action of cyclooxygenase. Since 19657 was isolated and since, as a vasodilator, after a long period of animal experiments and clinical applications have proved that PGEI has a wide range of pharmacological effects. In recent years, there are a large number of reports of PGE; for the treatment of a variety of clinical diseases significant effect.